Laparoscopic Versus Open Liver Resection for Colorectal Liver Metastases: A Comprehensive Systematic Review and Meta-analysis

被引:0
作者
Si-Ming Xie
Jun-Jie Xiong
Xue-Ting Liu
Hong-Yu Chen
Daniel Iglesia-García
Kiran Altaf
Shameena Bharucha
Wei Huang
Quentin M. Nunes
Peter Szatmary
Xu-Bao Liu
机构
[1] West China Hospital of Sichuan University,Department of Gastrointestinal Surgery
[2] People’s Hospital of Deyang,Departments of Pancreatic Surgery
[3] West China Hospital of Sichuan University,Department of gastrointestinal Surgery
[4] West China Hospital of Sichuan University,Clinical Directorate of General Surgery
[5] Royal Liverpool and Broadgreen University Hospitals NHS Trust,undefined
来源
Scientific Reports | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The effects of laparoscopic liver resection (LLR) and open liver resection (OLR) on oncological outcomes for colorectal cancer liver metastases (CCLM) remain inconclusive. Major databases were searched from January 1992 to October 2016. Effects of LLR vs OLR were determined. The primary endpoints were oncological outcomes. In total, 32 eligible non-randomized studies with 4697 patients (LLR: 1809, OLR: 2888) were analyzed. There were higher rates of clear surgical margins (OR: 1.64, 95%CI: 1.32 to 2.05, p < 0.00001) in the LLR group, without significant differences in disease recurrence, 3- or 5-year overall survival(OS) and disease free survival(DFS) between the two approaches. LLR was associated with less intraoperative blood loss (WMD: −147.46 [−195.78 to −99.15] mL, P < 0.00001) and fewer blood transfusions (OR: 0.41 [0.30–0.58], P < 0.00001), but with longer operation time (WMD:14.44 [1.01 to 27.88] min, P < 0.00001) compared to OLR. Less overall morbidity (OR: 0.64 [0.55 to 0.75], p < 0.00001) and shorter postoperative hospital stay (WMD: −2.36 [−3.06 to −1.66] d, p < 0.00001) were observed for patients undergoing LLR, while there was no statistical difference in mortality. LLR appears to be a safe and feasible alternative to OLR in the treatment of CCLM in selected patients.
引用
收藏
相关论文
共 173 条
  • [1] Brenner H(2014)Colorectal cancer Lancet. 383 1490-1502
  • [2] Kloor M(2015)Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States Gastroenterology. 149 1731-1741
  • [3] Pox CP(2006)Epidemiology and management of liver metastases from colorectal cancer Ann Surg. 244 254-259
  • [4] Peery AF(2002)Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg. 235 759-766
  • [5] Manfredi S(2004)Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg. 239 818-825
  • [6] Choti MA(2005)Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma J Clin Oncol 23 2038-2048
  • [7] Abdalla EK(2006)Improving resectability of hepatic colorectal metastases: expert consensus statement Ann Surg Oncol. 13 1271-1280
  • [8] Leonard GD(2008)Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet. 371 1007-1016
  • [9] Brenner B(2008)Surgery vs surgery and chemotherapy for colorectal liver metastases Lancet. 372 202-203
  • [10] Kemeny NE(1992)Laparoscopic partial hepatectomy for liver tumor Surgical Endoscopy 6 97-98